表紙
市場調査レポート

人工心臓装置の世界市場:2015〜2019年

Global Cardiac Prosthetic Devices Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 332629
出版日 ページ情報 英文 96 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
人工心臓装置の世界市場:2015〜2019年 Global Cardiac Prosthetic Devices Market 2015-2019
出版日: 2015年06月10日 ページ情報: 英文 96 Pages
概要

ステント、人工心臓弁などの人工心臓装置は、心臓の適切な機能を維持するために用いられます。ステントは動脈の閉塞により阻害される血流を維持するのに使われ、人工心臓弁は心臓弁の疾患、障害をもつ患者に用いられます。世界の人工心臓装置市場は、2014〜2019年にかけCAGR8.41%で拡大すると予測されています。

当レポートでは、世界の人工心臓装置市場について詳細に分析し、市場の動向と2015〜2019年の成長見通し、パイプライン分析、製品別、地域別動向、および主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 当レポートの範囲

第4章 調査方法

第5章 イントロダクション

第6章 市場環境

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 心臓弁手術のコスト分析

第8章 パイプライン製品

第9章 製品別世界の人工心臓装置市場セグメンテーション

第10章 世界の冠動脈ステント市場

  • 市場規模と予測
  • タイプ別セグメンテーション

第11章 世界の心臓弁市場

  • 市場規模と予測
  • 機械弁
  • 組織弁
  • 経カテーテル心臓弁

第12章 地域別セグメンテーション

  • 欧州・中東・アフリカ
  • 南北アメリカ
  • アジア太平洋地域

第13章 購入基準

第14章 市場成長促進因子

第15章 促進因子とその影響

第16章 市場の課題

第17章 促進因子と課題の影響

第18章 市場動向

第19章 動向とその影響

第20章 ベンダー環境

  • 競合シナリオ
  • 市場シェア調査:2014年
  • その他の将来的見込みのあるベンダー

第21章 主要ベンダー調査

  • Boston Scientific
  • Edwards Lifesciences
  • Medtronic
  • ソーリン・グループ株式会社
  • St. Jude Medical

第22章 当シリーズの他のレポート

目次
Product Code: IRTNTR6055

About cardiac prosthetic devices

Prosthetic devices are used to replace or support the function of a missing or infirm part in the body. Cardiac prosthetic devices such as stents and prosthetic heart valves are used to maintain the proper functionality of the heart. Stents are used to maintain the blood flow, which reduces due to blockage in the arteries, whereas prosthetic heart valves are being used by patient with heart valvular disease or dysfunctional heart valve.

Technavio's analysts forecast the global cardiac prosthetic market to grow at a CAGR of 8.41% over the period 2014-2019.

Covered in this report

The report covers the present scenario and the growth prospects of the global cardiac prosthetic market for the period 2015-2019. The market can be segmented into two based on products: prosthetic heart valves and coronary stents.

Technavio's report, the Global Cardiac Prosthetic Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the global cardiac prosthetic market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Boston Scientific
  • Edwards Lifesciences
  • Medtronic
  • Sorin Group
  • St. Jude Medical

Other Prominent Vendors

  • AorTech International
  • Abbott Vascular
  • Accellent
  • Admedes Schuessler
  • Alvimedica
  • Arbor Surgical
  • B. Braun Melsungen
  • Biosensors International
  • Biotronik
  • Boston Scientific
  • Bracco AMT
  • Colibri Heart Valve
  • Elixir Medical
  • eucatech
  • Eurocor
  • Hexacath
  • InspireMD
  • InSitu Technologies
  • iVascular
  • LEPU MEDICAL
  • Meril Life Sciences
  • Merit Medical
  • OrbusNeich
  • QT Vascular
  • Rontis
  • SCITECH
  • Shanghai MicroPort Scientific
  • STENTYS
  • Svelte Medical Systems
  • Symetis
  • Translumina

Market driver

  • Rise in birth prevalence of congenital heart disease worldwide
  • For a full, detailed list, view our report

Market challenge

  • Risk of complications and re-interventions
  • For a full, detailed list, view our report

Market trend

  • Increase in use of low-profile stents grafts for aneurysm repair
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Cost Analysis of Heart Valve Procedures

08. Pipeline Products

09. Global Cardiac Prosthetic Devices Market Segmentation by Product Type

10. Global Coronary Stents Market

  • 10.1. Market Size and Forecast
  • 10.2. Segmentation of Global Coronary Stents Market by Type

11. Global Heart Valves Market

  • 11.1. Market Size and Forecast
  • 11.2. Mechanical Heart Valves
    • 11.2.1. Market Size and Forecast
  • 11.3. Tissue Heart Valves
    • 11.3.1. Market Size and Forecast
  • 11.4. Transcatheter Heart Valves
    • 11.4.1. Market Size and Forecast

12. Geographical Segmentation

  • 12.1. Cardiac Prosthetic Devices Market in EMEA
    • 12.1.1. Market Size and Forecast
  • 12.2. Cardiac Prosthetic Devices Market in Americas
    • 12.2.1. Facility and Physician Billing Guide for Heart Valve Technologies in 2015
    • 12.2.2. Reimbursement Scenario for Cardiac Prosthetic Devices in US
    • 12.2.3. Market Size and Forecast
  • 12.3. Cardiac Prosthetic Devices Market in APAC
    • 12.3.1. Market Size and Forecast

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

  • 20.1. Competitive Scenario
    • 20.1.1. Key News
    • 20.1.2. Mergers and Acquisitions
  • 20.2. Market Share Analysis 2014
  • 20.3. Other Prominent Vendors

21. Key Vendor Analysis

  • 21.1. Boston Scientific
    • 21.1.1. Key Facts
    • 21.1.2. Business Overview
    • 21.1.3. Business Segmentation
    • 21.1.4. Business Segmentation by Revenue 2013
    • 21.1.5. Business Segmentation by Revenue 2012 and 2013
    • 21.1.6. Geographical Segmentation by Revenue 2013
    • 21.1.7. Business Strategy
    • 21.1.8. Recent Developments
    • 21.1.9. SWOT Analysis
  • 21.2. Edwards Lifesciences
    • 21.2.1. Key Facts
    • 21.2.2. Business Overview
    • 21.2.3. Business Segmentation by Revenue 2013
    • 21.2.4. Business Segmentation by Revenue 2012 and 2013
    • 21.2.5. Geographical Segmentation by Revenue 2013
    • 21.2.6. Business Strategy
    • 21.2.7. Recent Information
    • 21.2.8. SWOT Analysis
  • 21.3. Medtronic
    • 21.3.1. Key Facts
    • 21.3.2. Business Overview
    • 21.3.3. Business Segmentation
    • 21.3.4. Revenue by Business Segmentation
    • 21.3.5. Revenue Comparison by Business Segmentation 2012 and 2013
    • 21.3.6. Revenue by Geographical Segmentation
    • 21.3.7. Business Strategy
    • 21.3.8. Key Developments
    • 21.3.9. SWOT Analysis
  • 21.4. Sorin Group
    • 21.4.1. Key Facts
    • 21.4.2. Business Overview
    • 21.4.3. Business Segmentation by Revenue 2014
    • 21.4.4. Business Segmentation by Revenue 2013 and 2014
    • 21.4.5. Geographical Segmentation by Revenue 2014
    • 21.4.6. Business Strategy
    • 21.4.7. Recent Developments
    • 21.4.8. SWOT Analysis
  • 21.5. St. Jude Medical
    • 21.5.1. Key Facts
    • 21.5.2. Business Description
    • 21.5.3. Business Segmentation
    • 21.5.4. Business Strategy
    • 21.5.5. Revenue Segmentation by Business
    • 21.5.6. Revenue by Geographical Segmentation
    • 21.5.7. Key Information
    • 21.5.8. SWOT Analysis

22. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Cardiac Prosthetic Devices Market 2014-2019 ($ millions)
  • Exhibit 3: Types of Surgical Option
  • Exhibit 4: Segmentation of Global Cardiac Prosthetic Devices Market by Product Type
  • Exhibit 5: Segmentation of Global Cardiac Prosthetic Devices Market by Product Type 2014
  • Exhibit 6: Global Coronary Stents Market 2014-2019 ($ millions)
  • Exhibit 7: Segmentation of Coronary Stents by Type
  • Exhibit 8: Segmentation of Coronary Stents by Type 2014
  • Exhibit 9: Segmentation of Cardiac Prosthetic Heart Valves by Type
  • Exhibit 10: Global Heart Valves Market 2014-2019 ($ millions)
  • Exhibit 11: Segmentation of Mechanical Heart Valves by Type
  • Exhibit 12: Biomaterials used in Different Valves
  • Exhibit 13: Characteristics of Mechanical Valves
  • Exhibit 14: Global Mechanical Heart Valves Market 2014-2019 ($ millions)
  • Exhibit 15: Global Tissue Heart Valves Market 2014-2019 ($ millions)
  • Exhibit 16: Global Transcatheter Heart Valves Market 2014-2019 ($ millions)
  • Exhibit 17: Segmentation of Cardiac Prosthetic Heart Devices 2014
  • Exhibit 18: Segmentation of Cardiac Prosthetic Heart Devices 2014-2019
  • Exhibit 19: Segmentation of Cardiac Prosthetic Heart Devices 2014-2019
  • Exhibit 20: Segmentation of Global Cardiac Prosthetic Devices Market 2014
  • Exhibit 21: Cardiac Prosthetic Devices Market in EMEA 2014-2019 ($ millions)
  • Exhibit 22: Cardiac Prosthetic Devices Market in Americas 2014-2019 ($ millions)
  • Exhibit 23: Cardiac Prosthetic Devices Market in APAC 2014-2019 ($ millions)
  • Exhibit 24: Segmentation of Global Cardiac Prosthetic Devices Market by Geography 2014-2019
  • Exhibit 25: Segmentation of Global Cardiac Prosthetic Devices Market by Geography 2014-2019 ($ millions)
  • Exhibit 26: Key Takeaways: Boston Scientific
  • Exhibit 27: Key Takeaways: Edwards Lifesciences
  • Exhibit 28: Key Takeaways: Medtronic
  • Exhibit 29: Key Takeaways: Sorin
  • Exhibit 30: Key Takeaways: St. Jude Medical
  • Exhibit 31: Boston Scientific: Business Segmentation
  • Exhibit 32: Boston Scientific: Business Segmentation by Revenue 2013
  • Exhibit 33: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 34: Boston Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 35: Edwards Lifesciences: Business Segmentation by Revenue 2013
  • Exhibit 36: Edwards Lifesciences: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 37: Edwards Lifesciences: Geographical Segmentation by Revenue 2013
  • Exhibit 38: Medtronic Inc.: Business Segmentation
  • Exhibit 39: Medtronic Inc.: Revenue by Business Segmentation 2013
  • Exhibit 40: Medtronic Inc.: Revenue Comparison by Business Segmentation 2012 and 2013 (US$ million)
  • Exhibit 41: Medtronic Inc.: Revenue by Geographical Segmentation 2013
  • Exhibit 42: Sorin Group: Business Segmentation by Revenue 2014
  • Exhibit 43: Sorin Group: Business Segmentation by Revenue 2013 and 2014 ($ million)
  • Exhibit 44: Sorin Group: Geographical Segmentation by Revenue 2014
  • Exhibit 45: St. Jude Medical: Business Segmentation
  • Exhibit 46: St. Jude Medical: Revenue by Business Segmentation 2013
  • Exhibit 47: St. Jude Medical: Revenue by Geographical Segmentation 2012
Back to Top